Compare Abbott Laboratories (ABT) vs United States Copper Index Fund (CPER) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs United States Copper Index Fund — how do they compare? Abbott Laboratories trades at $94.9 (market cap $166.94B), while United States Copper Index Fund trades at $37.06. The key difference: Abbott Laboratories pays a 2.63% dividend while United States Copper Index Fund pays none, and United States Copper Index Fund is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | CPER | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $136.62 | $40.60 |
52-Week Low | $82.57 | $27.21 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
CPER, the United States Copper Index Fund ETF, trades at $37.84, up 1.47% today. The technical outlook is mixed, with a bullish moving average signal but neutral overall momentum. Recent news highlights strong copper demand from AI and electric vehicles, though supply constraints and price volatility are key themes. Financial ratios are not applicable as this is a commodity ETF tracking copper futures.
The outlook for CPER is tied to copper's structural bull market, driven by AI and green energy demand. Risks include global manufacturing weakness and commodity price swings. Investor sentiment is positive due to copper's supply-demand imbalance, but the ETF's performance remains sensitive to macroeconomic factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About United States Copper Index Fund
CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.
Read more on CPER →
